The study of Lacroix et al. [
[1]
] highlights the importance that should be given to the treatment of climacteric comorbidities.
As in previous studies with other antidepressants [
2
,
3
], the efficacy of escitalopram in the improvement of vasomotor symptoms was also demonstrated.To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to MaturitasAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Effects of escitalopram on menopause-specific quality of life and pain in healthy menopausal women with hot flashes: a randomized controlled trial.Maturitas. 2012; (in press)
- Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial.JAMA. 2011; 305: 267-274
- Assessing risks and benefits of nonhormonal treatments for vasomotor symptoms in perimenopausal and postmenopausal women.Journal of Women's Health (Larchmt). 2011; 20: 1007-1016
- Venlafaxine in the treatment of depressive and vasomotor symptoms in women with perimenopausal depression.Depression and Anxiety. 2005; 22: 94-97
- Yoga decreases insomnia in postmenopausal women: a randomized clinical trial.Menopause. 2012; 19: 186-193
- Effect of therapeutic massage on insomnia and climacteric symptoms in postmenopausal women.Climacteric. 2012; 15: 21-29
Article info
Publication history
Published online: November 01, 2012
Received:
October 17,
2012
Identification
Copyright
© 2012 Elsevier Ireland Ltd. Published by Elsevier Inc. All rights reserved.
